by Combat Cancer | Mar 25, 2022 | Uncategorized
The Medical Innovators Interview #4 Dr Alvaro ArjonaFebruary 2022 Minimally invasive surgery vs open surgery, refining the laparoscopic approach for peritoneal carcinomatosis, AI and a key trial for HIPEC® in T4 colon cancer. Combat Medical’s Guy Cooper is discussing...
by Combat Cancer | Mar 25, 2022 | Uncategorized
The Medical Innovators Interview #3 Helena BurdenDecember 2021 Welcome to the third of our new series of interviews with medical innovators – in conversation with Miss Helena Burden, consultant urology surgeon at the Bristol Urological Institute, Southmead Hospital,...
by Combat Cancer | Mar 25, 2022 | Uncategorized
The Medical Innovators Interview with Associate Professor Ahmad Sayasneh | November 2021 The regular use of HIPEC for ovarian cancer, along with improving pre-surgical diagnostics and visualisation interoperatively, could be a real game-changer. Consultant...
by Combat Cancer | Mar 25, 2022 | Uncategorized
Welcome to Combat Medical’s first Medical Innovators interview series, where we’ll be exploring ideas and developments in the medical and clinical worlds with the people at the, ahem, cutting edge. To kick off, we’re talking haematuria, urine biomarkers and...
Recent Comments